 |
|
|
|
UV Lamps
|
#1. Suberythemogenic Narrow-band UVB is Markedly More Effective Than Conventional UVB in Treatment of Psoriasis Vulgaris. Ian B. Walters, MD; Lauren H. Burack, MD; Todd R. Coven, MD; Patricia Gilleaudeau, RN, BSN; James G. Krueger, MD, PhD. Journal of the American Academy of Dermatology Vol 40, Number 6, Part 1. June 1999 |
|
Eleven patients treated using split-body approach, three times a week, for six weeks. Able to induce clinical clearing in 81.8% of patients after NB-UVB, but only 9.1% after BB-UVB.
CONCLUSION: NB-UVB is superior to UVB-BB in reversing psoriasis at suberythemogenic doses when given three times per week. This schedule was well tolerated by all patients |
|
|
#2. A Randomized Comparison of Narrow-band TL-01 Phototherapy and PUVA Photochemotherapy for Psoriasis. P. M. Gordon, MRCP; B. L. Diffey, PhD; J. N. S. Matthews, PhD; and P. M. Farr, MD. Journal of American Academy of Dermatology
Vol 41, Number 5, Part 1. November 1999 |
|
100 patients were randomly allocated with twice-weekly treatments with PUVA or narrow-band UVB. Clearance of psoriasis was achieved in 84% of PUVA patients vs 63% with TL-01. Plus, the PUVA success took significantly fewer treatments.
CONCLUSION: When given twice weekly, PUVA is more effective for psoriasis than narrow-band UVB phototherapy |
|
|
#3. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. W. Westerhof and L. Nieuweboer-Krobotova. Archives of Dermatology. Vol 133. No. 12. December 1997. Compared efficacy and safety of 2 treatment modalities, topical psoralen plus UV-A (PUVA) with unsubstituted psoralen and 311-nm UV-B radiation, in patients with vitiligo. |
CONCLUSION: Treatment of patients with vitiligo with 311-nm UV-B radiation is as efficient as with topical PUVA and has fewer adverse effects. Foundational study has been cited by many later articles.”
|
|
|
|
